BOSTON, MA – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced a significant minority investment in BioGlyph, a startup biotech software company that is developing technology to visually illustrate, register, and model biologic molecules including, specifically, multispecific antibodies (MsAbs). BioGlyph possesses proprietary technology and exceptional talent in the realm of […]
Investment in Oxford Nanopore, innovators of a transformational new generation of sensing technology that today specialises in DNA/RNA sequencing £50m to be invested by Novo Holdings as part of an equity issue Novo Holdings intends to make further share purchases over time in the secondary market, subject to availability and price (among other factors) […]
New funds will support ongoing commercial activities in Europe, the U.S and Asia and further enhance the development of a next-generation single-cell cloning platform OXFORD, UK — iotaSciences, the Oxford-based leader in single-cell biology handling solutions has successfully raised an equity round in new growth funding to continue expansion of its pioneering business related to single-cell biology […]
WOBURN, Mass. — Spear Bio Inc., a biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment, announced the successful closing of its $45 million Series A financing. The oversubscribed round was co-led by Foresite Capital and Bio-Techne Corporation, with additional participation from existing investors including Maverick Ventures, […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced its participation in Spear Bio’s $45 million Series A funding round. Spear Bio will use the proceeds from this funding round to further accelerate product development and scale its in-house manufacturing capacity. Bio-Techne joined Foresite Capital, and other investors, in this funding round. Founded in 2021 and headquartered […]
New funding will expand CytoReason’s disease models and proprietary data, enabling R&D leaders at partner companies to make strategic decisions with greater speed and precision. CytoReason will use this investment to expand the application of its models into additional indications, grow its proprietary molecular and clinical data, and establish an office in Cambridge, Massachusetts later […]
With Briefly Bio scientists no longer need to reinvent the wheel – spending time and resources on experiments that they can’t reproduce. LONDON, UK — Science is in a reproducibility crisis. In preclinical research, it’s estimated that over 50% of efforts to reproduce experiments fail, costing the industry over $50bn each year. Solving this problem, […]
Granatus Ventures’ portfolio Modicus Prime announced today the completion of a $3.5M in series seed funding led by Silverton Partners, with additional backing from Alumni Ventures and other leading venture firms. The funding comes following the implementation of the cloud software across multiple global pharmaceutical companies, CMOs, and CDMOs manufacturing biologics, cell and gene therapies, and vaccines. Modicus […]
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of […]
SAN DIEGO, CA – Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced over $277 million in Series D investment to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for years to come. The oversubscribed round was led by Wellington Management with participation from new and existing […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
